Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy (Q33623763)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

anti-retroviral agent

0 references

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Myron J Levin

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

5

object named as

Sharon A Nachman

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Stephen I Pelton

6

object named as

Stephen I Pelton

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Mark J Abzug

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Meredith Warshaw

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Howard M Rosenblatt

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

William Borkowsky

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Terence Fenton

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

International Maternal Pediatric Adolescent AIDS Clinical Trials Group P1024 and P1061s Protocol Teams

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

language of work or name

0 references

publication date

1 September 2009

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

200

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

935-946

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Effect of highly active antiretroviral therapy on the serological response to additional measles vaccinations in human immunodeficiency virus-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Response of HIV/AIDS Patients to Hepatitis B Recombinant Vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Response to hepatitis B immunization by infants exposed to HIV.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Impaired response to hepatitis B vaccine in HIV infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

21 June 2018

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Persistence of antibody and immunologic memory in children immunized with hepatitis B vaccine at birth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Ten-year serological follow up of hepatitis B vaccine recipients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Hepatitis B vaccination in infants of mothers infected with human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2814776

30 October 2018

Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody response to hepatitis B vaccine in infants of HIV positive mothers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of hepatitis B surface antibody levels after vaccination with a recombinant hepatitis B vaccine: a 3-year follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunization of HIV-infected children with varicella vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poor responses to recombinant HBV vaccination in patients with HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19663708

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33623763&oldid=1970133029"